Showing results (71-80 of 80) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 80 results.
The Science of the Total Environment|March 20, 2021
COVID-19 containment on a college campus via wastewater-based epidemiology, targeted clinical testing and an interventionWalter Q Betancourt, Bradley W Schmitz, Gabriel K Innes, et al.
Radiology|October 4, 2022
Multicenter Reproducibility of Liver Iron Quantification with 1.5-T and 3.0-T MRIDiego Hernando, Ruiyang Zhao, Qing Yuan, et al.
Journal of Magnetic Resonance Imaging : JMRI|April 25, 2024
Practical Application of Multivendor MRI-Based R2* Mapping for Liver Iron Quantification at 1.5 T and 3.0 TGregory Simchick, Ruiyang Zhao, Qing Yuan, et al.
Magnetic Resonance in Medicine|September 6, 2024
Multicenter, multivendor validation of liver quantitative susceptibility mapping in patients with iron overload at 1.5 T and 3 TCollin J Buelo, Julia Velikina, Lu Mao, et al.
Medical Physics|June 9, 2021
Multisite multivendor validation of a quantitative MRI and CT compatible fat phantomRuiyang Zhao, Diego Hernando, David T Harris, et al.
Hepatology (Baltimore, Md.)|March 25, 2025
Proton density fat fraction for diagnosis of metabolic dysfunction-associated steatotic liver diseaseNikolaos Panagiotopoulos, Tanya Wolfson, David T Harris, et al.
Biomedicines|June 2, 2021
SARS-CoV-2 Rapid Antigen Testing of Symptomatic and Asymptomatic Individuals on the University of Arizona CampusDavid T Harris, Michael Badowski, Brandon Jernigan, et al.
Radiology|May 5, 2026
Comparative Precision of 3D MRE and 2D MRE for Measurement of Liver Stiffness in Adults with Severe ObesityLukas Müller, Lael Ceriani, David T Harris, et al.
Immunity|November 1, 2020
Orthogonal SARS-CoV-2 Serological Assays Enable Surveillance of Low-Prevalence Communities and Reveal Durable Humoral ImmunityTyler J Ripperger, Jennifer L Uhrlaub, Makiko Watanabe, et al.
Medrxiv : the Preprint Server for Health Sciences|August 21, 2020
Detection, prevalence, and duration of humoral responses to SARS-CoV-2 under conditions of limited population exposureTyler J Ripperger, Jennifer L Uhrlaub, Makiko Watanabe, et al.
Pageof 8